ABVC BioPharma Analyst Ratings
ABVC BioPharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | — | Maxim Group | Downgrades | Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/16/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 |
What is the target price for ABVC BioPharma (ABVC)?
ABVC BioPharma（ABVC）的目標價格是多少？
The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on November 16, 2022. The analyst firm set a price target for $0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Maxim集團於2022年11月16日公佈了ABVC BioPharma（納斯達克股票代碼：ABVC）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計ABVC將在12個月內跌至12個月內（可能下跌-100.00％）。1家分析公司去年公佈了評級。
What is the most recent analyst rating for ABVC BioPharma (ABVC)?
ABVC BioPharma（ABVC）的最新分析師評級是多少？
The latest analyst rating for ABVC BioPharma (NASDAQ: ABVC) was provided by Maxim Group, and ABVC BioPharma downgraded their hold rating.
馬克西姆集團提供了ABVC BioPharma（納斯達克股票代碼：ABVC）的最新分析師評級，ABVC BioPharma下調了持有評級。
When is the next analyst rating going to be posted or updated for ABVC BioPharma (ABVC)?
ABVC BioPharma（ABVC）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ABVC BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ABVC BioPharma was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與ABVC BioPharma的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。ABVC BioPharma的最新評級是在2022年11月16日公佈的，因此您應該預計下一個評級將在2023年11月16日左右公佈。
Is the Analyst Rating ABVC BioPharma (ABVC) correct?
分析師對ABVC BioPharma（ABVC）的評級是否正確？
While ratings are subjective and will change, the latest ABVC BioPharma (ABVC) rating was a downgraded with a price target of $0.00 to $0.00. The current price ABVC BioPharma (ABVC) is trading at is $0.76, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的ABVC BioPharma（ABVC）評級已下調，目標股價爲0.00美元至0.00美元。ABVC BioPharma（ABVC）目前的交易價格爲0.76美元，超出了分析師的預期區間。